Abstract:To the editor: The prognosis of in-hospital and out-of-hospital cardiac arrest (CA) is awfully poor. Most causes are reported to thromboembolism diseases, i.e. massive pulmonary embolism (MPE) and acute myocardial infarction (AMI). Systemic thrombolysis during cardiopulmonary resuscitation (CPR) is still controversial, for fear of potentially lethal hemorrhage. A 23-year-old woman presented to our emergency room (ER) with chill and fever for 2 days, along with two times of emesis and melena, chest distress and light headedness. She had also been troubled with autoimmune hemolytic anemia (AIHA) for more than 10 years and bronchial asthma for 3 years. Ultrasound of both the upper and lower extremities where done in ER showed no evidence of deep vein thrombosis, and a moderate risk was achieved by Well's criteria for PE. Then she was admitted to intensive care unit. About 4 hours later, a sudden CA occurred. A 12-lead electrocardiogram briefly before CA revealed sinus tachycardia, incomplete right bundle-branch block as well as T inversion in leads V1-4 compared with that at admission just showing sinus tachycardia. Echocardiography during CPR displayed right ventricular dilatation and moderate pulmonary hypertension, compared to that at admission nearly normal state. However, refractory pulseless electrical activity appeared after 20-minute consistent CPR. MPE was potentially considered. The drug recombinant tissue plasminogen activator (rt-PA) therefore was prescribed. The resuscitation was continued for next 55 minutes until the return of spontaneous circulation (ROSC) was achieved. Chest computed tomographic pulmonary angiography (CTPA) and cerebral CT were therefore implemented after 4 hour-observation. Apparent bilateral pulmonary embolism was discovered (Figure 1), while without obvious intracranial hemorrhage. She regained her consciousness 6 hours later after recovery of ROSC, without evident neurological deficits.Figure 1.: Chest computed tomographic pulmonary angiography demonstrating bilateral arterial embolism (→).Debate existed whether or not using thrombolysis during CPR, while the subgroup of patients with MPE or AMI might benefit from it.1 When to start it was another key factor, as longer-CPR could induce potentially greater hemorrhage complication and mortality. Two large retrospective studies had revealed that autoimmune diseases including AIHA, pertaining to blood hypercoagulation, increased the risk of subsequent venous thromboembolism (VTE) and PE.2,3 Coagulation disturbance was always complicating from severe sepsis. Both AIHA and severe sepsis occurred in the case, indicating high risk of VTE. Subcutaneous low-molecular weight heparin or unfractionated heparin could be prescribed for prophylaxis or treatment of VTE. However, a dilemma of thrombotic and bleeding risk might coexist. Antithrombotic therapy was not initiated at admission in the case, considering the gastrointestinal and urinary bleeding. In summary, any new intervention has to be studied and evaluated carefully in view of the poor prognosis of CA. Since AIHA, as other autoimmune disorders presented hypercoagulability feature, unexpected thromboembolism event has to be prevented intentionally. Thrombolysis with rt-PA during CPR after CA, caused by presumed MPE, should be started early. This case also indicated the strategy might be effective and safe even within prolonged CPR, though which should be evaluated by further large randomized controlled trial. Jianping Gao Konghan Pan Kejing Ying Critical Care Department (Gao JP and Pan KH), Respiratory Department (Ying KJ), Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China Correspondence to: Dr. Ying Kejing, Respiratory Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China (Tel: 86-571-86006606. Fax: 86-571-86044817. Email: [email protected])

Lung Entrapment Secondary to Loculated Rheumatoid Effusions Treated With Alteplase and Dornase

Pleural Involvement in Rheumatoid Arthritis

Non-surgical Management of an Abrupt Cavitation and Large Oval-Shaped Lung Abscess Secondary to Acute Thromboembolic Pulmonary Infarction: a Case Report

Thrombolysis During Prolonged Resuscitation after Cardiac Arrest Caused by Presumed Pulmonary Embolism

Thrombolysis During Extended Cardiopulmonary Resuscitation for Autoimmune-Related Pulmonary Embolism

Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy

The removal of floating right heart thrombi and pulmonary embolus using AngioJet device and venoarterial extracorporeal membrane oxygenation: a case report

Treatment of acute pulmonary embolism using rheolytic thrombectomy

Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study

Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion

Management of Pulmonary Embolism with Rheolytic Thrombectomy

Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials

Efficacy and Safety of Recombinant Human Tumor Necrosis Factor Application for the Treatment of Malignant Pleural Effusion Caused by Lung Cancer

A Comparative Study of the Safety and Efficacy of Intrapleural Fibrinolysis With Streptokinase and Urokinase in the Management of Loculated Pleural Effusions

Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema

Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits

[Long-term outcome of intrapleural fibrinolytic therapy via small-bore catheter drainage in the management of complicated parapneumonic effusion and empyema-a case series]

Intrapleural Fibrinolytic Therapy With Alteplase for the Management of Multiloculated Malignant Pleural Effusion: A Case Series

Intrapleural fibrinolysis for parapneumonic effusion and empyema in children

Conservative Treatment of Empyema Formation Following Intrathoracic Rib Fixation With Antibiotics and Tissue Plasminogen Activator/Dornase

Intrapleural Fibrinolytic Therapy for Residual Coagulated Hemothorax After Lung Surgery